Tag: CHPA
Industry Reacts to Study “Wrongly” Comparing Supplements to Rx
Washington, D.C.—A recent Cleveland Clinic trial compared common dietary supplements to a low-dose cholesterol-lowering medication (a statin). The study was funded by AstraZeneca, which markets Rosuvastatin....
COSMOS-Mind Study Shows Promise for Multivitamins in Cognition
Washington, D.C.—The ancillary study of the Cocoa Supplement and Multivitamin Outcomes Study for the Mind (COSMOS-Mind) study, conducted by the Wake Forest University School of Medicine...
Senate HELP FDA Authorization Bill Passes Committee; Industry Groups “Strongly Concerned”
Washington, D.C.—Earlier this year, the Senate Health, Education, Labor, and Pensions (HELP) Committee released a discussion draft of legislation to reauthorize FDA user fees...
CRN: News Reports “Grossly Misrepresent” CDC Report on Melatonin
Washington, D.C.—As WholeFoods Magazine previously reported, the Centers for Disease Control (CDC) recently released data regarding the use of melatonin in children. The study authors...
CHPA Spotlights Public Education Initiatives on Melatonin
Washington, D.C.—As WholeFoods Magazine previously reported, the Centers for Disease Control (CDC) has released data regarding the use of melatonin in children. The finding:...
People News: June 2022
The Global Organization for EPA and DHA Omega-3s (GOED) welcomed new hire Ashley Becnel, who joins the organization in the role of Global Business...
Dietary Supplement Listing Act of 2022 Introduced; Industry Divided
Washington, D.C.—The Dietary Supplement Listing Act of 2022 has been introduced by Senators Richard Durbin (D-IL) and Mike Braun (R-IN) with the intent of...
Industry Reacts to FDA FY 2023 Budget Request; Proposal to Modernize Dietary Supplement Regulation
The U.S. Food and Drug Administration (FDA) announced that its request for a total budget of $8.4 billion as part of the President’s fiscal...
CHPA Launches Index to Analyze Trends in Supplements
Aventura, FL—The Consumer Healthcare Products Association (CHPA) has introduced the Dietary Supplement Index (DSX), a data-driven tool that collates market data, geographic and demographic...
CHPA Responds to JAMA Report on Melatonin Usage
JAMA has released a report titled “Trends in Use of Melatonin Supplements Among U.S. Adults, 1999-2018,” created using data from 55,021 adults from 10...
